Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series
Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis wa...
Gespeichert in:
Veröffentlicht in: | Virchows Archiv : an international journal of pathology 1998-07, Vol.433 (1), p.19-27 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 27 |
---|---|
container_issue | 1 |
container_start_page | 19 |
container_title | Virchows Archiv : an international journal of pathology |
container_volume | 433 |
creator | STREGE, R. J SAEGER, W LINKE, R. P |
description | Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis was the most common type, being found in 21 cases (48.8%). Transthyretin-derived (ATTR) amyloidosis was present in 11 cases (25.6%), and immunoglobulin light chain-derived (AL) amyloidosis in 10 cases (23.3%). A single case (2.3%) contained deposits of more than one type of systemic amyloid. AA amyloidosis was associated with chronic inflammatory or infectious diseases (81%), malignant tumours (19%) or both (9.5%). Immunoglobulin light chain-derived amyloidoses were associated with myeloma (50%) or primary (idiopathic; 50%). In AA and AL amyloidosis the kidney was the organ most frequently involved. ATTR amyloid affecting mostly the heart and lungs presented as senile systemic amyloidosis. Systemic amyloidosis was the cause of death in 5 cases (12%) and caused symptoms in 17 cases (39%). Our results suggest that most cases can be classified by using a panel of sensitive and specific antibodies against five major amyloid fibril proteins. This technique may make amyloid type-specific therapy possible for AL amyloid patients who do not have evidence of an underlying plasma cell dyscrasia. |
doi_str_mv | 10.1007/s004280050211 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_80044582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80044582</sourcerecordid><originalsourceid>FETCH-LOGICAL-p235t-25babd4407725e952ac4fb2be64c9ac93d4cc7fb318289977387a02c036441843</originalsourceid><addsrcrecordid>eNo9kEtLxDAUhYMo4zi6dClkIe6qebVJ3cn4hAFBdF3SNHUibVJ700UX_nczOLi6h3s-zuJD6JySa0qIvAFCBFOE5IRReoCWVHCWMU7kIVqSUuRZwak8RicAXyQhihYLtCiLkilGl-jn3ulPH8AB1r7Bru8nH7YOYjBb2zujO2w6DeDalKMLHocWwwxxV2Ldz11wTQAL-Ba_2SGMcQcIjo3ePZ1Ps3jyYDtrom2wnmIYYMZgR2fhFB21ugN7tr8r9PH48L5-zjavTy_ru002MJ7HjOW1rhshiJQst2XOtBFtzWpbCFNqU_JGGCPbmlPFVFlKyZXUhBnCCyGoEnyFrv52hzF8TxZi1Tswtuu0t2GCKukTIlcsgRd7cKp721TD6Ho9ztXeV-ov972G5KYdtTcO_rGknSrC-S-duHpt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80044582</pqid></control><display><type>article</type><title>Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>STREGE, R. J ; SAEGER, W ; LINKE, R. P</creator><creatorcontrib>STREGE, R. J ; SAEGER, W ; LINKE, R. P</creatorcontrib><description>Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis was the most common type, being found in 21 cases (48.8%). Transthyretin-derived (ATTR) amyloidosis was present in 11 cases (25.6%), and immunoglobulin light chain-derived (AL) amyloidosis in 10 cases (23.3%). A single case (2.3%) contained deposits of more than one type of systemic amyloid. AA amyloidosis was associated with chronic inflammatory or infectious diseases (81%), malignant tumours (19%) or both (9.5%). Immunoglobulin light chain-derived amyloidoses were associated with myeloma (50%) or primary (idiopathic; 50%). In AA and AL amyloidosis the kidney was the organ most frequently involved. ATTR amyloid affecting mostly the heart and lungs presented as senile systemic amyloidosis. Systemic amyloidosis was the cause of death in 5 cases (12%) and caused symptoms in 17 cases (39%). Our results suggest that most cases can be classified by using a panel of sensitive and specific antibodies against five major amyloid fibril proteins. This technique may make amyloid type-specific therapy possible for AL amyloid patients who do not have evidence of an underlying plasma cell dyscrasia.</description><identifier>ISSN: 0945-6317</identifier><identifier>EISSN: 1432-2307</identifier><identifier>DOI: 10.1007/s004280050211</identifier><identifier>PMID: 9692821</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Aged ; Aged, 80 and over ; Amyloidosis ; Amyloidosis - classification ; Amyloidosis - metabolism ; Amyloidosis - pathology ; Biological and medical sciences ; Female ; Humans ; Immunohistochemistry ; Male ; Medical sciences ; Metabolic diseases ; Middle Aged ; Other metabolic disorders ; Serum Amyloid A Protein - analysis</subject><ispartof>Virchows Archiv : an international journal of pathology, 1998-07, Vol.433 (1), p.19-27</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2301803$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9692821$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>STREGE, R. J</creatorcontrib><creatorcontrib>SAEGER, W</creatorcontrib><creatorcontrib>LINKE, R. P</creatorcontrib><title>Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series</title><title>Virchows Archiv : an international journal of pathology</title><addtitle>Virchows Arch</addtitle><description>Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis was the most common type, being found in 21 cases (48.8%). Transthyretin-derived (ATTR) amyloidosis was present in 11 cases (25.6%), and immunoglobulin light chain-derived (AL) amyloidosis in 10 cases (23.3%). A single case (2.3%) contained deposits of more than one type of systemic amyloid. AA amyloidosis was associated with chronic inflammatory or infectious diseases (81%), malignant tumours (19%) or both (9.5%). Immunoglobulin light chain-derived amyloidoses were associated with myeloma (50%) or primary (idiopathic; 50%). In AA and AL amyloidosis the kidney was the organ most frequently involved. ATTR amyloid affecting mostly the heart and lungs presented as senile systemic amyloidosis. Systemic amyloidosis was the cause of death in 5 cases (12%) and caused symptoms in 17 cases (39%). Our results suggest that most cases can be classified by using a panel of sensitive and specific antibodies against five major amyloid fibril proteins. This technique may make amyloid type-specific therapy possible for AL amyloid patients who do not have evidence of an underlying plasma cell dyscrasia.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Amyloidosis</subject><subject>Amyloidosis - classification</subject><subject>Amyloidosis - metabolism</subject><subject>Amyloidosis - pathology</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Middle Aged</subject><subject>Other metabolic disorders</subject><subject>Serum Amyloid A Protein - analysis</subject><issn>0945-6317</issn><issn>1432-2307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLxDAUhYMo4zi6dClkIe6qebVJ3cn4hAFBdF3SNHUibVJ700UX_nczOLi6h3s-zuJD6JySa0qIvAFCBFOE5IRReoCWVHCWMU7kIVqSUuRZwak8RicAXyQhihYLtCiLkilGl-jn3ulPH8AB1r7Bru8nH7YOYjBb2zujO2w6DeDalKMLHocWwwxxV2Ldz11wTQAL-Ba_2SGMcQcIjo3ePZ1Ps3jyYDtrom2wnmIYYMZgR2fhFB21ugN7tr8r9PH48L5-zjavTy_ru002MJ7HjOW1rhshiJQst2XOtBFtzWpbCFNqU_JGGCPbmlPFVFlKyZXUhBnCCyGoEnyFrv52hzF8TxZi1Tswtuu0t2GCKukTIlcsgRd7cKp721TD6Ho9ztXeV-ov972G5KYdtTcO_rGknSrC-S-duHpt</recordid><startdate>19980701</startdate><enddate>19980701</enddate><creator>STREGE, R. J</creator><creator>SAEGER, W</creator><creator>LINKE, R. P</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19980701</creationdate><title>Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series</title><author>STREGE, R. J ; SAEGER, W ; LINKE, R. P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p235t-25babd4407725e952ac4fb2be64c9ac93d4cc7fb318289977387a02c036441843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Amyloidosis</topic><topic>Amyloidosis - classification</topic><topic>Amyloidosis - metabolism</topic><topic>Amyloidosis - pathology</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Middle Aged</topic><topic>Other metabolic disorders</topic><topic>Serum Amyloid A Protein - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>STREGE, R. J</creatorcontrib><creatorcontrib>SAEGER, W</creatorcontrib><creatorcontrib>LINKE, R. P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Virchows Archiv : an international journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>STREGE, R. J</au><au>SAEGER, W</au><au>LINKE, R. P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series</atitle><jtitle>Virchows Archiv : an international journal of pathology</jtitle><addtitle>Virchows Arch</addtitle><date>1998-07-01</date><risdate>1998</risdate><volume>433</volume><issue>1</issue><spage>19</spage><epage>27</epage><pages>19-27</pages><issn>0945-6317</issn><eissn>1432-2307</eissn><abstract>Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis was the most common type, being found in 21 cases (48.8%). Transthyretin-derived (ATTR) amyloidosis was present in 11 cases (25.6%), and immunoglobulin light chain-derived (AL) amyloidosis in 10 cases (23.3%). A single case (2.3%) contained deposits of more than one type of systemic amyloid. AA amyloidosis was associated with chronic inflammatory or infectious diseases (81%), malignant tumours (19%) or both (9.5%). Immunoglobulin light chain-derived amyloidoses were associated with myeloma (50%) or primary (idiopathic; 50%). In AA and AL amyloidosis the kidney was the organ most frequently involved. ATTR amyloid affecting mostly the heart and lungs presented as senile systemic amyloidosis. Systemic amyloidosis was the cause of death in 5 cases (12%) and caused symptoms in 17 cases (39%). Our results suggest that most cases can be classified by using a panel of sensitive and specific antibodies against five major amyloid fibril proteins. This technique may make amyloid type-specific therapy possible for AL amyloid patients who do not have evidence of an underlying plasma cell dyscrasia.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>9692821</pmid><doi>10.1007/s004280050211</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0945-6317 |
ispartof | Virchows Archiv : an international journal of pathology, 1998-07, Vol.433 (1), p.19-27 |
issn | 0945-6317 1432-2307 |
language | eng |
recordid | cdi_proquest_miscellaneous_80044582 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Aged Aged, 80 and over Amyloidosis Amyloidosis - classification Amyloidosis - metabolism Amyloidosis - pathology Biological and medical sciences Female Humans Immunohistochemistry Male Medical sciences Metabolic diseases Middle Aged Other metabolic disorders Serum Amyloid A Protein - analysis |
title | Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T01%3A49%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosis%20and%20immunohistochemical%20classification%20of%20systemic%20amyloidoses%20:%20Report%20of%2043%20cases%20in%20an%20unselected%20autopsy%20series&rft.jtitle=Virchows%20Archiv%20:%20an%20international%20journal%20of%20pathology&rft.au=STREGE,%20R.%20J&rft.date=1998-07-01&rft.volume=433&rft.issue=1&rft.spage=19&rft.epage=27&rft.pages=19-27&rft.issn=0945-6317&rft.eissn=1432-2307&rft_id=info:doi/10.1007/s004280050211&rft_dat=%3Cproquest_pubme%3E80044582%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80044582&rft_id=info:pmid/9692821&rfr_iscdi=true |